I did in silico study (molecular docking) of anti-malarial compounds' candidates that target the falciparin-2 and plasmodium falciparum dihydrofolate reductase-thymidylate synthase proteins and also in vitro study that target the plasmodium falciparum strain 3D7.
Interestingly, the in silico data and in vitro data are not consistent. Why these phenomenon could be happen? Are there any justification to discuss this phenomenon?
Thanks in advance